SpaceX Still Trades Above Its IPO Price. Could Anthropic Do the Same?

Anthropic is reportedly targeting a November IPO that could raise roughly $100 billion at a $2 trillion valuation, following leaked S-1 details showing a $42 billion 2025 loss, including $34 billion of non-cash convertible-debt valuation adjustments. The company reported Q2 revenue growth of more than 1,000% to $11.5 billion, supporting the argument that its valuation could compress rapidly relative to sales. SpaceX's stabilization at roughly 10% above its $135 IPO price after an early surge and subsequent decline is presented as a favorable precedent, though Anthropic faces material AI-safety and potential legal-liability risks.

Analysis

The relevant read-through is not whether a prior marquee IPO held its issue price, but whether public-market liquidity can absorb another mega-capital raise without forcing a reset in AI risk premia. Anthropic's reported loss is largely non-cash, but the economics that matter are cash burn per incremental dollar of enterprise revenue, inference gross margin, and the terms of compute commitments. A November deal would likely pull forward institutional allocation from NVDA, MSFT, GOOGL and AMZN rather than create incremental AI demand, creating a 2-6 week relative-performance headwind in the most crowded AI complex.

Anthropic's safety positioning is a double-edged valuation input. It can lower enterprise adoption friction in regulated verticals and support premium pricing, but disclosures around model misuse create a more tangible litigation and regulatory discount than investors are assigning to frontier-model peers. The near-term upside case requires a clean third-quarter revenue and margin print; the 6-18 month question is whether revenue growth converts into declining compute intensity and positive contribution margins before contractual infrastructure obligations become balance-sheet constraints.

Consensus is overusing SpaceX as a valuation analog. SpaceX has differentiated physical assets, government-linked demand and potentially less direct product substitution, while Anthropic competes in a market where model performance leadership can shift rapidly and large distribution partners retain bargaining power. A successful IPO may therefore validate AI funding appetite, but it would not validate a durable software-like multiple for Anthropic unless retention, net revenue expansion and inference margins are disclosed.

Key Decisions for Investors

• Maintain NVDA exposure but hedge the November IPO window with a 1-2 month NVDA/QQQ relative-value short overlay; a large allocation rotation is the nearer-term risk, while the hedge should be covered if hyperscaler capex guidance remains intact or NVDA closes the next earnings cycle with upward revenue revisions.
• Prefer long AMZN versus GOOGL over the next 3-6 months as an indirect Anthropic beneficiary only if AWS discloses accelerating Bedrock usage or Anthropic-related consumption; AWS captures infrastructure spend, while the trade fails if Anthropic diversifies compute materially or AWS margins weaken from capacity investment.
• Do not chase SPCX as an IPO-comparability trade. Treat any sharp sympathy rally as a trim/short-term fade candidate absent new contract, launch-cadence, or cash-flow evidence; its post-listing stabilization says little about another issuer's terminal multiple.
• Set an IPO diligence alert rather than establish a pre-deal position: require disclosed annualized revenue, customer concentration, remaining performance obligations, compute commitments, cash burn, and stock-based-compensation terms. A valuation near the indicated level is investable only if net revenue retention and gross margin demonstrate improving unit economics; otherwise expect a 20-35% post-lockup de-rating risk within 6-12 months.